291 related articles for article (PubMed ID: 34152229)
1. Roles of Angioplasty With Drug-Coated Balloon for Chronic Ischemia in Wound Healing.
Hata Y; Iida O; Ito N; Soga Y; Fukunaga M; Kawasaki D; Fujihara M; Kozuki A; Takahara M; Mano T
J Endovasc Ther; 2021 Oct; 28(5):778-787. PubMed ID: 34152229
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
[No Abstract] [Full Text] [Related]
3. Angiographic patterns of restenosis after drug-coated balloon angioplasty for femoropopliteal lesions and 1-year prognosis after repeat endovascular therapy.
Higashino N; Iida O; Ishihara T; Hata Y; Toyoshima T; Tsukizawa T; Nishian K; Fujihara M; Kawasaki D; Mano T
Catheter Cardiovasc Interv; 2023 Nov; 102(6):1114-1121. PubMed ID: 37855184
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
Imran HM; Hyder ON; Soukas PA
Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease.
Cantu D; Jawaid O; Kokkinidis D; Giannopoulos S; Valle JA; Waldo SW; Singh GD; Armstrong EJ
Cardiovasc Revasc Med; 2020 Jul; 21(7):867-874. PubMed ID: 31761636
[TBL] [Abstract][Full Text] [Related]
6. Comparative 12-Month Outcomes of Drug-Coated Balloon Versus Non-Drug-Coated Balloon Revascularization Strategy in Chronic Limb-Threatening Ischemia: Results From the XLPAD Registry.
Giannopoulos S; Jeon-Slaughter H; Kahlon RS; Tejani I; Baskar A; Banerjee S; Armstrong EJ
Cardiovasc Revasc Med; 2020 Oct; 21(10):1276-1284. PubMed ID: 32249170
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
Rodoplu O; Oztas DM; Meric M; Beyaz MO; Ulukan MO; Yildiz CE; Unal O; Ugurlucan M
Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
[TBL] [Abstract][Full Text] [Related]
8. Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of Infrapopliteal Artery Lesions (AcoArt II-BTK).
Jia X; Zhuang B; Wang F; Gu Y; Zhang J; Lu X; Dai X; Liu Z; Bi W; Liu C; Wang S; Liistro F; Guo W
J Endovasc Ther; 2021 Apr; 28(2):215-221. PubMed ID: 33118432
[TBL] [Abstract][Full Text] [Related]
9. Frequency, predictors, and effect of the slow-flow phenomenon after drug-coated balloon angioplasty for femoropopliteal lesions.
Shirai S; Hirano K; Mori S; Makino K; Honda Y; Tsutsumi M; Sakamoto Y; Kobayashi N; Araki M; Yamawaki M; Ito Y
Heart Vessels; 2021 Dec; 36(12):1818-1824. PubMed ID: 34050788
[TBL] [Abstract][Full Text] [Related]
10. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
[TBL] [Abstract][Full Text] [Related]
11. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
[TBL] [Abstract][Full Text] [Related]
12. [Mid- and long-term outcomes and prognostic factors of drug-coated balloon angioplasty for treatment of femoropopliteal long lesions].
Cao ZJ; Zhang T; Zhao KQ; Zhao JL; Yu XH; Li YW; Wu WW
Zhonghua Wai Ke Za Zhi; 2022 Jan; 60(1):57-62. PubMed ID: 34954948
[No Abstract] [Full Text] [Related]
13. Outcomes of non-flow-limiting spiral dissection after drug-coated balloon angioplasty for de novo femoropopliteal lesions.
Haraguchi T; Kuramitsu S; Tsujimoto M; Kashima Y; Sato K; Fujita T
Catheter Cardiovasc Interv; 2024 Jan; 103(1):97-105. PubMed ID: 37975201
[TBL] [Abstract][Full Text] [Related]
14. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
[TBL] [Abstract][Full Text] [Related]
15. Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac Trial.
Teichgräber U; Lehmann T; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Blessing E; Lichtenberg M; von Flotow P; Heilmeier B; Sixt S; Brucks S; Erbel C; Beschorner U; Werk M; Riambau V; Wienke A; Klumb CT; Thieme M
Radiology; 2020 May; 295(2):478-487. PubMed ID: 32125256
[TBL] [Abstract][Full Text] [Related]
16. Intraluminal vs Subintimal Drug-Coated Balloon Angioplasty for the Treatment of Femoropopliteal Chronic Total Occlusions.
Toyoshima T; Takahara M; Iida O; Tomoi Y; Kawasaki D; Tanaka A; Yamauchi Y; Tobita K; Kozuki A; Fujihara M; Higuchi Y; Soga Y;
JACC Cardiovasc Interv; 2024 Mar; 17(5):608-618. PubMed ID: 38479962
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.
Kobayashi T; Hamamoto M; Okazaki T; Hasegawa M; Fujiwara T; Takahashi S
Vascular; 2021 Dec; 29(6):905-912. PubMed ID: 33349196
[TBL] [Abstract][Full Text] [Related]
18. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
[TBL] [Abstract][Full Text] [Related]
19. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions.
Kokkinidis DG; Jawaid O; Cantu D; Martinsen BJ; Igyarto Z; Valle JA; Waldo SW; Armstrong EJ
J Endovasc Ther; 2020 Jun; 27(3):492-501. PubMed ID: 32364000
[No Abstract] [Full Text] [Related]
20. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
